Ardelyx reported $5.8M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Amgen USD 653M 32M Dec/2025
Ardelyx USD 5.8M 784K Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Curis USD 178K 441K Dec/2023
Sanofi EUR -25M 99.78M Dec/2025
TG Therapeutics USD 6.72M 4K Sep/2025
United Therapeutics USD 3M 4.3M Sep/2025
Xoma USD 3.4M 150K Jun/2024